HERPES SIMPLEX 2
Clinical trials for HERPES SIMPLEX 2 explained in plain language.
Never miss a new study
Get alerted when new HERPES SIMPLEX 2 trials appear
Sign up with your email to follow new studies for HERPES SIMPLEX 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cold sore drug slow Alzheimer's?
Disease control CompletedThis study tested whether the antiviral drug valacyclovir (Valtrex) could slow brain changes linked to Alzheimer's in 50 people with mild cognitive impairment who also had herpes simplex virus antibodies. Participants took either valacyclovir or a placebo for 52 weeks. The goal w…
Matched conditions: HERPES SIMPLEX 2
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a common cold sore drug slow Alzheimer's? new study explores the link.
Disease control CompletedThis study tested whether the antiviral drug valacyclovir (Valtrex) can slow memory loss in people with mild Alzheimer's disease who also carry the herpes simplex virus. About 120 participants received either the drug or a placebo for 18 months. The goal was to see if treating th…
Matched conditions: HERPES SIMPLEX 2
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC